Abstract
Exosomes are involved in a wide variety of biochemical processes in human body homeostasis. Exosomes also provide important information regarding communications among several organ systems. Additionally, they can serve as molecular vehicles to deliver drugs. Therefore, exosomes have received wide attention in current biomedical research for unraveling pathogenic mechanisms of diseases, searching for novel biomarkers, and discovering new drugs. This paper reviews and discusses the significance of urinary exosomes for a better understanding of human disease pathophysiology and their potential use as therapeutic targets. Isolation methods of exosomes and the latest technological advances are also discussed. Furthermore, novel urinary exosomal biomarkers are highlighted with special emphasis on their clinical applicability (particularly sensitivity, specificity, reliability, and other aspects). Finally, future trends for this field are analyzed and our perspectives are provided.
Similar content being viewed by others
References
Colombo M, Raposo G, Thery C (2014) Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Ann Rev Cell Dev Biol 30:255–289. https://doi.org/10.1146/annurev-cellbio-101512-122326
Raposo G, Stoorvogel W (2013) Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 200(4):373–383. https://doi.org/10.1083/jcb.201211138
Vlassov AV, Magdaleno S, Setterquist R, Conrad R (2012) Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochem Biophys Acta 1820(7):940–948. https://doi.org/10.1016/j.bbagen.2012.03.017
Barros ER, Carvajal CA (2017) Urinary exosomes and their cargo: potential biomarkers for mineralocorticoid arterial hypertension? Front Endocrinol (Lausanne) 8:230–230. https://doi.org/10.3389/fendo.2017.00230
Camussi G, Deregibus MC, Bruno S, Cantaluppi V, Biancone L (2010) Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int 78(9):838–848. https://doi.org/10.1038/ki.2010.278
Dear JW, Street JM, Bailey MA (2013) Urinary exosomes: a reservoir for biomarker discovery and potential mediators of intrarenal signalling. Proteomics 13(10–11):1572–1580. https://doi.org/10.1002/pmic.201200285
Lässer C, Alikhani VS, Ekström K, Eldh M, Paredes PT, Bossios A, Sjöstrand M, Gabrielsson S, Lötvall J, Valadi H (2011) Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages. J Transl Med 9:9–9. https://doi.org/10.1186/1479-5876-9-9
Palanisamy V, Sharma S, Deshpande A, Zhou H, Gimzewski J, Wong DT (2010) Nanostructural and transcriptomic analyses of human saliva derived exosomes. PLoS ONE 5(1):e8577. https://doi.org/10.1371/journal.pone.0008577
Thakur BK, Zhang H, Becker A, Matei I, Huang Y, Costa-Silva B, Zheng Y, Hoshino A, Brazier H, Xiang J, Williams C, Rodriguez-Barrueco R, Silva JM, Zhang W, Hearn S, Elemento O, Paknejad N, Manova-Todorova K, Welte K, Bromberg J, Peinado H, Lyden D (2014) Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res 24(6):766–769. https://doi.org/10.1038/cr.2014.44
Tu M, Wei F, Yang J, Wong D (2015) Detection of exosomal biomarker by electric field-induced release and measurement (EFIRM). J Vis Exp JoVE 95:52439. https://doi.org/10.3791/52439
Pegtel DM, Gould SJ (2019) Exosomes. Ann Rev Biochem 88:487–514
Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9(6):654–659
Zomer A, Maynard C, Verweij FJ, Kamermans A, Schäfer R, Beerling E, Schiffelers RM, de Wit E, Berenguer J, Ellenbroek SIJ (2015) In vivo imaging reveals extracellular vesicle-mediated phenocopying of metastatic behavior. Cell 161(5):1046–1057
McKiernan J, Donovan MJ, O’Neill V, Bentink S, Noerholm M, Belzer S, Skog J, Kattan MW, Partin A, Andriole G (2016) A novel urine exosome gene expression assay to predict high-grade prostate cancer at initial biopsy. JAMA Oncol 2(7):882–889
Hoshino A, Costa-Silva B, Shen T-L, Rodrigues G, Hashimoto A, Mark MT, Molina H, Kohsaka S, Di Giannatale A, Ceder S (2015) Tumour exosome integrins determine organotropic metastasis. Nature 527(7578):329–335
Lambert AW, Pattabiraman DR, Weinberg RA (2017) Emerging biological principles of metastasis. Cell 168(4):670–691
Howitt J, Hill AF (2016) Exosomes in the pathology of neurodegenerative diseases. J Biol Chem 291(52):26589–26597
Mulcahy LA, Pink RC, Carter DR (2014) Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles. https://doi.org/10.3402/jev.v3.24641
Kim MS, Haney MJ, Zhao Y, Mahajan V, Deygen I, Klyachko NL, Inskoe E, Piroyan A, Sokolsky M, Okolie O, Hingtgen SD, Kabanov AV, Batrakova EV (2016) Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomed Nanotechnol Biol Med 12(3):655–664. https://doi.org/10.1016/j.nano.2015.10.012
Tsoi KM, MacParland SA, Ma X-Z, Spetzler VN, Echeverri J, Ouyang B, Fadel SM, Sykes EA, Goldaracena N, Kaths JM, Conneely JB, Alman BA, Selzner M, Ostrowski MA, Adeyi OA, Zilman A, McGilvray ID, Chan WCW (2016) Mechanism of hard-nanomaterial clearance by the liver. Nat Mater 15(11):1212–1221. https://doi.org/10.1038/nmat4718
Li X, Corbett AL, Taatizadeh E, Tasnim N, Little JP, Garnis C, Daugaard M, Guns E, Hoorfar M, Li ITS (2019) Challenges and opportunities in exosome research—perspectives from biology, engineering, and cancer therapy. APL Bioeng 3(1):011503. https://doi.org/10.1063/1.5087122
Yang T, Martin P, Fogarty B, Brown A, Schurman K, Phipps R, Yin VP, Lockman P, Bai S (2015) Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio. Pharm Res 32(6):2003–2014. https://doi.org/10.1007/s11095-014-1593-y
Cheng J, Nonaka T, Wong DTW (2019) salivary exosomes as nanocarriers for cancer biomarker delivery. Materials (Basel, Switzerland). https://doi.org/10.3390/ma12040654
Herreros-Villanueva M, Bujanda L (2016) Non-invasive biomarkers in pancreatic cancer diagnosis: what we need versus what we have. Ann Transl Med 4(7):134. https://doi.org/10.21037/atm.2016.03.44
Huebner AR, Somparn P, Benjachat T, Leelahavanichkul A, Avihingsanon Y, Fenton RA, Pisitkun T (2015) Exosomes in urine biomarker discovery. Adv Exp Med Biol 845:43–58. https://doi.org/10.1007/978-94-017-9523-4_5
Beasley-Green A (2016) Urine proteomics in the era of mass spectrometry. Int Neurourol J 20(Suppl 2):S70–S75. https://doi.org/10.5213/inj.1612720.360
Lange T, Artelt N, Kindt F, Stracke S, Rettig R, Lendeckel U, Chadjichristos CE, Kavvadas P, Chatziantoniou C, Endlich K (2019) MiR-21 is up-regulated in urinary exosomes of chronic kidney disease patients and after glomerular injury. J Cell Mol Med 23(7):4839
Sonoda H, Lee BR, Park K-H, Nihalani D, Yoon J-H, Ikeda M, Kwon S-H (2019) miRNA profiling of urinary exosomes to assess the progression of acute kidney injury. Sci Rep 9(1):1–11
Gheinani AH, Vögeli M, Baumgartner U, Vassella E, Draeger A, Burkhard FC, Monastyrskaya K (2018) Improved isolation strategies to increase the yield and purity of human urinary exosomes for biomarker discovery. Sci Rep 8(1):1–17
Ayala-Mar S, Donoso-Quezada J, Gallo-Villanueva RC, Perez-Gonzalez VH, González-Valdez J (2019) Recent advances and challenges in the recovery and purification of cellular exosomes. Electrophoresis 40(23–24):3036–3049
Doyle LM, Wang MZ (2019) Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells 8(7):727
Thongboonkerd V (2019) Roles for exosome in various kidney diseases and disorders. Front Pharmacol. https://doi.org/10.3389/fphar.2019.01655
Lin J, Li J, Huang B, Liu J, Chen X, Chen X-M, Xu Y-M, Huang L-F, Wang X-Z (2015) Exosomes: novel biomarkers for clinical diagnosis. Sci World J 2015:8. https://doi.org/10.1155/2015/657086
Chen CC, Liu L, Ma F, Wong CW, Guo XE, Chacko JV, Farhoodi HP, Zhang SX, Zimak J, Ségaliny A (2016) Elucidation of exosome migration across the blood–brain barrier model in vitro. Cell Mol Bioeng 9(4):509–529
Chen Y, Xie Y, Xu L, Zhan S, Xiao Y, Gao Y, Wu B, Ge W (2017) Protein content and functional characteristics of serum-purified exosomes from patients with colorectal cancer revealed by quantitative proteomics. Int J Cancer 140(4):900–913
Soung YH, Ford S, Zhang V, Chung J (2017) Exosomes in cancer diagnostics. Cancers 9(1):8
Solé C, Moliné T, Vidal M, Ordi-Ros J, Cortés-Hernández J (2019) An exosomal urinary miRNA signature for early diagnosis of renal fibrosis in lupus nephritis. Cells 8(8):773
Zaporozhchenko IA, Bryzgunova OE, Lekchnov EA, Osipov ID, Zaripov MM, Yurchenko YB, Yarmoschuk SV, Pashkovskaya OA, Rykova EY, Zheravin AA, Laktionov PP (2018) Representation analysis of miRNA in urine microvesicles and cell-free urine in prostate diseases. Biochem Suppl Ser B Biomed Chem 12(2):156–163. https://doi.org/10.1134/s1990750818020142
Turturici G, Tinnirello R, Sconzo G, Geraci F (2014) Extracellular membrane vesicles as a mechanism of cell-to-cell communication: advantages and disadvantages. Am J Physiol Cell Physiol 306(7):C621–C633
Villa F, Quarto R, Tasso R (2019) Extracellular vesicles as natural, safe and efficient drug delivery systems. Pharmaceutics 11(11):557
Zhuang X, Xiang X, Grizzle W, Sun D, Zhang S, Axtell RC, Ju S, Mu J, Zhang L, Steinman L (2011) Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol Ther 19(10):1769–1779
Antes TJ, Middleton RC, Luther KM, Ijichi T, Peck KA, Liu WJ, Valle J, Echavez AK, Marbán E (2018) Targeting extracellular vesicles to injured tissue using membrane cloaking and surface display. J Nanobiotechnol 16(1):1–15
Ryu A-R, Kim DH, Kim E, Lee MY (2018) The potential roles of extracellular vesicles in cigarette smoke-associated diseases. Oxidative Med Cell Longev. https://doi.org/10.1155/2018/4692081
Maas SLN, Breakefield XO, Weaver AM (2017) Extracellular vesicles: unique intercellular delivery vehicles. Trends Cell Biol 27(3):172–188. https://doi.org/10.1016/j.tcb.2016.11.003
Tkach M, Thery C (2016) Communication by extracellular vesicles: where we are and where we need to go. Cell 164(6):1226–1232. https://doi.org/10.1016/j.cell.2016.01.043
van Niel G, D’Angelo G, Raposo G (2018) Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol 19(4):213–228. https://doi.org/10.1038/nrm.2017.125
Yuana Y, Levels J, Grootemaat A, Sturk A, Nieuwland R (2014) Co-isolation of extracellular vesicles and high-density lipoproteins using density gradient ultracentrifugation. J Extracell Vesicles. https://doi.org/10.3402/jev.v3403.23262
Sonoda H, Lee BR, Park K-H, Nihalani D, Yoon J-H, Ikeda M, Kwon S-H (2019) miRNA profiling of urinary exosomes to assess the progression of acute kidney injury. Sci Rep 9(1):4692. https://doi.org/10.1038/s41598-019-40747-8
Cheng H, Fang H, Xu RD, Fu MQ, Chen L, Song XY, Qian JY, Zou YZ, Ma JY, Ge JB (2019) Development of a rinsing separation method for exosome isolation and comparison to conventional methods. Eur Rev Med Pharmacol Sci 23(12):5074–5083. https://doi.org/10.26355/eurrev_201906_18171
Lan T, Xi X, Chu Q, Zhao L, Chen A, Lu JJ, Wang F, Zhang W (2018) A preliminary origin-tracking study of different densities urinary exosomes. Electrophoresis 39(18):2316–2320. https://doi.org/10.1002/elps.201700388
Gupta S, Rawat S, Arora V, Kottarath SK, Dinda AK, Vaishnav PK, Nayak B, Mohanty S (2018) An improvised one-step sucrose cushion ultracentrifugation method for exosome isolation from culture supernatants of mesenchymal stem cells. Stem Cell Res Therapy 9(1):1–11
Wu Y, Deng W, Klinke DJ 2nd (2015) Exosomes: improved methods to characterize their morphology, RNA content, and surface protein biomarkers. Analyst 140(19):6631–6642. https://doi.org/10.1039/c5an00688k
Sharma S, Rasool HI, Palanisamy V, Mathisen C, Schmidt M, Wong DT, Gimzewski JK (2010) Structural-mechanical characterization of nanoparticle exosomes in human saliva, using correlative AFM, FESEM, and force spectroscopy. ACS Nano 4(4):1921–1926. https://doi.org/10.1021/nn901824n
Awdishu L, Tsunoda S, Pearlman M, Kokoy-Mondragon C, Ghassemian M, Naviaux RK, Patton HM, Mehta RL, Vijay B, RamachandraRao SP (2019) Identification of maltase glucoamylase as a biomarker of acute kidney injury in patients with cirrhosis. Critic Care Res Pract. https://doi.org/10.1155/2019/5912804
Awdishu L, Tsunoda S, Pearlman M, Kokoy-Mondragon C, Ghassemian M, Naviaux RK, Patton HM, Mehta RL, Vijay B, RamachandraRao SP (2019) Identification of maltase glucoamylase as a biomarker of acute kidney injury in patients with cirrhosis. Crit Care Res Pract 2019:5912804. https://doi.org/10.1155/2019/5912804
Carvajal C, Herrada A, Castillo C, Contreras F, Stehr C, Mosso L, Kalergis A, Fardella C (2009) Primary aldosteronism can alter peripheral levels of transforming growth factor β and tumor necrosis factor α. J Endocrinol Invest 32(9):759–765
Stehr CB, Mellado R, Ocaranza MP, Carvajal CA, Mosso L, Becerra E, Solis M, García L, Lavandero S, Jalil J (2010) Increased levels of oxidative stress, subclinical inflammation, and myocardial fibrosis markers in primary aldosteronism patients. J Hypertens 28(10):2120–2126
Zhu X, Manning RD Jr, Lu D, Gomez-Sanchez CE, Fu Y, Juncos LA, Liu R (2011) Aldosterone stimulates superoxide production in macula densa cells. Am J Physiol Renal Physiol 301(3):F529–F535
Carvajal CA, Herrada AA, Castillo CR, Contreras FJ, Stehr CB, Mosso LM, Kalergis AM, Fardella CE (2009) Primary aldosteronism can alter peripheral levels of transforming growth factor beta and tumor necrosis factor alpha. J Endocrinol Invest 32(9):759–765. https://doi.org/10.3275/6429
10.1007/bf03346533.
Stehr CB, Mellado R, Ocaranza MP, Carvajal CA, Mosso L, Becerra E, Solis M, Garcia L, Lavandero S, Jalil J, Fardella CE (2010) Increased levels of oxidative stress, subclinical inflammation, and myocardial fibrosis markers in primary aldosteronism patients. J Hypertens 28(10):2120–2126. https://doi.org/10.1097/HJH.0b013e32833d0177
Zhu X, Manning RD Jr, Lu D, Gomez-Sanchez CE, Fu Y, Juncos LA, Liu R (2011) Aldosterone stimulates superoxide production in macula densa cells. Am J Physiol Ren Physiol 301(3):F529-535. https://doi.org/10.1152/ajprenal.00596.2010
Feldman RD, Limbird LE (2017) GPER (GPR30): a nongenomic receptor (gpcr) for steroid hormones with implications for cardiovascular disease and cancer. Annu Rev Pharmacol Toxicol 57:567–584. https://doi.org/10.1146/annurev-pharmtox-010716-104651
Kuppusamy M, Gomez-Sanchez EP, Beloate LN, Plonczynski M, Naray-Fejes-Toth A, Fejes-Toth G, Gomez-Sanchez CE (2017) Interaction of the mineralocorticoid receptor with RACK1 and its role in aldosterone signaling. Endocrinology 158(7):2367–2375. https://doi.org/10.1210/en.2017-00095
Shibata S, Mu S, Kawarazaki H, Muraoka K, Ishizawa K, Yoshida S, Kawarazaki W, Takeuchi M, Ayuzawa N, Miyoshi J, Takai Y, Ishikawa A, Shimosawa T, Ando K, Nagase M, Fujita T (2011) Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway. J Clin Investig 121(8):3233–3243. https://doi.org/10.1172/jci43124
Tapia-Castillo A, Carvajal CA, Campino C, Hill C, Allende F, Vecchiola A, Carrasco C, Bancalari R, Valdivia C, Lagos C, Martinez-Aguayo A, Garcia H, Aglony M, Baudrand RF, Kalergis AM, Michea LF, Riedel CA, Fardella CE (2015) The expression of RAC1 and mineralocorticoid pathway-dependent genes are associated with different responses to salt intake. Am J Hypertens 28(6):722–728. https://doi.org/10.1093/ajh/hpu224
Ichai C, Bichet DG (2018) Water and sodium balance. Metabolic disorders and critically ill patients. Springer, Cham, pp 3–31
Rodríguez M, Bajo-Santos C, Hessvik NP, Lorenz S, Fromm B, Berge V, Sandvig K, Linē A, Llorente A (2017) Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes. Mol Cancer 16(1):156
Vives EG, Marcé CS, Vidal M, Cortés-Hernández J, Ordi-Ros J (2018) Urinary exosomes microRNAs: a future biomarkers in lupus patients with renal involvement. J Extracell Vesicles 7:174–174
Pathare G, Dhayat N, Mohebbi N, Wagner CA, Cheval L, Neuhaus TJ, Fuster DG (2018) Acute regulated expression of pendrin in human urinary exosomes. Pflügers Arch Eur J Physiol 470(2):427–438
Khurana R, Ranches G, Schafferer S, Lukasser M, Rudnicki M, Mayer G, Hüttenhofer A (2017) Identification of urinary exosomal noncoding RNAs as novel biomarkers in chronic kidney disease. RNA (New York, NY) 23(2):142–152. https://doi.org/10.1261/rna.058834.116
Lange T, Stracke S, Rettig R, Lendeckel U, Kuhn J, Schlüter R, Rippe V, Endlich K, Endlich N (2017) Identification of miR-16 as an endogenous reference gene for the normalization of urinary exosomal miRNA expression data from CKD patients. PLoS ONE. https://doi.org/10.1371/journal.pone.0183435
Khurana R, Ranches G, Schafferer S, Lukasser M, Rudnicki M, Mayer G, Hüttenhofer A (2017) Identification of urinary exosomal noncoding RNAs as novel biomarkers in chronic kidney disease. RNA 23(2):142–152
Dusso A, Colombo MI, Shanahan CM (2018) Not all vascular smooth muscle cell exosomes calcify equally in chronic kidney disease. Kidney Int 93(2):298–301
Chen NX, O’Neill KD, Moe SM (2018) Matrix vesicles induce calcification of recipient vascular smooth muscle cells through multiple signaling pathways. Kidney Int 93(2):343–354
Wang B, Zhang A, Wang H, Klein JD, Tan L, Wang Z-M, Du J, Naqvi N, Liu B-C, Wang XH (2019) miR-26a limits muscle wasting and cardiac fibrosis through exosome-mediated microRNA transfer in chronic kidney disease. Theranostics 9(7):1864
Shibata S, Mu S, Kawarazaki H, Muraoka K, Ishizawa K-i, Yoshida S, Kawarazaki W, Takeuchi M, Ayuzawa N, Miyoshi J (2011) Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor–dependent pathway. J Clin Investig 121(8):3233–3243
Zang J, Maxwell AP, Simpson DA, McKay GJ (2019) Differential expression of urinary exosomal microRNAs miR-21-5p and miR-30b-5p in Individuals with diabetic kidney disease. Sci Rep 9(1):10900. https://doi.org/10.1038/s41598-019-47504-x
Zang J, Maxwell AP, Simpson DA, McKay GJ (2019) Differential expression of urinary exosomal microRNAs miR-21-5p and miR-30b-5p in individuals with diabetic kidney disease. Sci Rep 9(1):1–10
Sakurai A, Ono H, Ochi A, Matsuura M, Yoshimoto S, Kishi S, Murakami T, Tominaga T, Nagai K, Abe H, Doi T (2019) Involvement of Elf3 on Smad3 activation-dependent injuries in podocytes and excretion of urinary exosome in diabetic nephropathy. PLoS ONE 14(5):e0216788. https://doi.org/10.1371/journal.pone.0216788
Li W, Yang S, Qiao R, Zhang J (2018) Potential value of urinary exosome-derived let-7c-5p in the diagnosis and progression of type II diabetic nephropathy. Clin Lab 64(5):709–718
Webber JP, Spary LK, Sanders AJ, Chowdhury R, Jiang WG, Steadman R, Wymant J, Jones AT, Kynaston H, Mason MD, Tabi Z, Clayton A (2015) Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes. Oncogene 34(3):290–302. https://doi.org/10.1038/onc.2013.560
Webber J, Steadman R, Mason MD, Tabi Z, Clayton A (2010) Cancer exosomes trigger fibroblast to myofibroblast differentiation. Cancer Res 70(23):9621–9630. https://doi.org/10.1158/0008-5472.can-10-1722
Todorova D, Simoncini S, Lacroix R, Sabatier F, Dignat-George F (2017) Extracellular vesicles in angiogenesis. Circ Res 120(10):1658–1673. https://doi.org/10.1161/CIRCRESAHA.117.309681
Zheng R, Du M, Wang X, Xu W, Liang J, Wang W, Lv Q, Qin C, Chu H, Wang M (2018) Exosome–transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression. Mol Cancer 17(1):143
Berrondo C, Flax J, Kucherov V, Siebert A, Osinski T, Rosenberg A, Fucile C, Richheimer S, Beckham CJ (2016) Expression of the long non-coding RNA HOTAIR correlates with disease progression in bladder cancer and is contained in bladder cancer patient urinary exosomes. PLoS ONE. https://doi.org/10.1371/journal.pone.0147236
Dhondt B, Van Deun J, Vermaerke S, de Marco A, Lumen N, De Wever O, Hendrix A (2018) Urinary extracellular vesicle biomarkers in urological cancers: from discovery towards clinical implementation. Int J Biochem Cell Biol 99:236–256. https://doi.org/10.1016/j.biocel.2018.04.009
Chen CL, Lai YF, Tang P, Chien KY, Yu JS, Tsai CH, Chen HW, Wu CC, Chung T, Hsu CW, Chen CD, Chang YS, Chang PL, Chen YT (2012) Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients. J Proteome Res 11(12):5611–5629. https://doi.org/10.1021/pr3008732
Lin SY, Chang CH, Wu HC, Lin CC, Chang KP, Yang CR, Huang CP, Hsu WH, Chang CT, Chen CJ (2016) Proteome profiling of urinary exosomes identifies alpha 1-antitrypsin and H2B1K as diagnostic and prognostic biomarkers for urothelial carcinoma. Sci Rep. https://doi.org/10.1038/srep34446
Silvers CR, Liu YR, Wu CH, Miyamoto H, Messing EM, Lee YF (2016) Identification of extracellular vesicle-borne periostin as a feature of muscle-invasive bladder cancer. Oncotarget 7(17):23335–23345. https://doi.org/10.18632/oncotarget.8024
Silvers CR, Miyamoto H, Messing EM, Netto GJ, Lee YF (2017) Characterization of urinary extracellular vesicle proteins in muscle-invasive bladder cancer. Oncotarget 8(53):91199–91208. https://doi.org/10.18632/oncotarget.20043
Perez A, Loizaga A, Arceo R, Lacasa I, Rabade A, Zorroza K, Mosen-Ansorena D, Gonzalez E, Aransay AM, Falcon-Perez JM, Unda-Urzaiz M, Royo F (2014) A pilot study on the potential of RNA-associated to urinary vesicles as a suitable non-invasive source for diagnostic purposes in bladder cancer. Cancers 6(1):179–192. https://doi.org/10.3390/cancers6010179
Berrondo C, Flax J, Kucherov V, Siebert A, Osinski T, Rosenberg A, Fucile C, Richheimer S, Beckham CJ (2016) Expression of the long non-coding RNA HOTAIR correlates with disease progression in bladder cancer and is contained in bladder cancer patient urinary exosomes. PLoS ONE 11(1):e0147236. https://doi.org/10.1371/journal.pone.0147236
Dijkstra S, Mulders PFA, Schalken JA (2014) Clinical use of novel urine and blood based prostate cancer biomarkers: a review. Clin Biochem 47(10):889–896. https://doi.org/10.1016/j.clinbiochem.2013.10.023
Deras IL, Aubin SM, Blase A, Day JR, Koo S, Partin AW, Ellis WJ, Marks LS, Fradet Y, Rittenhouse H, Groskopf J (2008) PCA3: a molecular urine assay for predicting prostate biopsy outcome. J Urol 179(4):1587–1592. https://doi.org/10.1016/j.juro.2007.11.038
Bryzgunova OE, Zaripov MM, Skvortsova TE, Lekchnov EA, Grigor’eva AE, Zaporozhchenko IA, Morozkin ES, Ryabchikova EI, Yurchenko YB, Voitsitskiy VE, Laktionov PP (2016) Comparative study of extracellular vesicles from the urine of healthy individuals and prostate cancer patients. PLoS ONE 11(6):e0157566. https://doi.org/10.1371/journal.pone.0157566
Bijnsdorp IV, Geldof AA, Lavaei M, Piersma SR, van Moorselaar RJ, Jimenez CR (2013) Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients. J Extracell Vesicles. https://doi.org/10.3402/jev.v2i0.22097
Donovan MJ, Noerholm M, Bentink S, Belzer S, Skog J, O’Neill V, Cochran JS, Brown GA (2015) A molecular signature of PCA3 and ERG exosomal RNA from non-DRE urine is predictive of initial prostate biopsy result. Prostate Cancer Prostatic Dis 18(4):370–375. https://doi.org/10.1038/pcan.2015.40
Royo F, Zuniga-Garcia P, Sanchez-Mosquera P, Egia A, Perez A, Loizaga A, Arceo R, Lacasa I, Rabade A, Arrieta E, Bilbao R, Unda M, Carracedo A, Falcon-Perez JM (2016) Different EV enrichment methods suitable for clinical settings yield different subpopulations of urinary extracellular vesicles from human samples. J Extracell Vesicles 5:29497. https://doi.org/10.3402/jev.v5.29497
Neeb A, Hefele S, Bormann S, Parson W, Adams F, Wolf P, Miernik A, Schoenthaler M, Kroenig M, Wilhelm K, Schultze-Seemann W, Nestel S, Schaefer G, Bu H, Klocker H, Nazarenko I, Cato ACB (2014) Splice variant transcripts of the anterior gradient 2 gene as a marker of prostate cancer. Oncotarget 5(18):8681–8689
Skotland T, Ekroos K, Kauhanen D, Simolin H, Seierstad T, Berge V, Sandvig K, Llorente A (2017) Molecular lipid species in urinary exosomes as potential prostate cancer biomarkers. Eur J Cancer 70:122–132. https://doi.org/10.1016/j.ejca.2016.10.011
Yang JS, Lee JC, Byeon SK, Rha KH, Moon MH (2017) Size dependent lipidomic analysis of urinary exosomes from patients with prostate cancer by flow field-flow fractionation and nanoflow liquid chromatography-tandem mass spectrometry. Anal Chem 89(4):2488–2496. https://doi.org/10.1021/acs.analchem.6b04634
Yang W-W, Yang L-Q, Zhao F, Chen C-W, Xu L-H, Fu J, Li S-L, Ge X-Y (2017) Epiregulin promotes lung metastasis of salivary adenoid cystic carcinoma. Theranostics 7(15):3700–3714. https://doi.org/10.7150/thno.19712
Rodriguez M, Bajo-Santos C, Hessvik NP, Lorenz S, Fromm B, Berge V, Sandvig K, Line A, Llorente A (2017) Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes. Mol Cancer 16(1):156. https://doi.org/10.1186/s12943-017-0726-4
Yazarlou F, Modarressi MH, Mowla SJ, Oskooei VK, Motevaseli E, Tooli LF, Nekoohesh L, Eghbali M, Ghafouri-Fard S, Afsharpad M (2018) Urinary exosomal expression of long non-coding RNAs as diagnostic marker in bladder cancer. Cancer Manag Res 10:6357–6365. https://doi.org/10.2147/cmar.s186108
Kurahashi R, Kadomatsu T, Baba M, Hara C, Itoh H, Miyata K, Endo M, Morinaga J, Terada K, Araki K, Eto M, Schmidt LS, Kamba T, Linehan WM, Oike Y (2019) MicroRNA-204–5p: a novel candidate urinary biomarker of Xp11.2 translocation renal cell carcinoma. Cancer Sci 110(6):1897–1908. https://doi.org/10.1111/cas.14026
Gu C-Y, Huang Y-Q, Han C-T, Zhu Y, Bo D, Meng J, Qin X-J, Ye D-W (2019) Clinical significance of urine prostatic exosomal protein in the diagnosis of prostate cancer. Am J Cancer Res 9(5):1074
Wang H, Lu Z, Zhao X (2019) Tumorigenesis, diagnosis, and therapeutic potential of exosomes in liver cancer. J Hematol Oncol 12(1):133
Di Meo A, Batruch I, Brown MD, Yang C, Finelli A, Jewett MAS, Diamandis EP, Yousef GM (2019) Identification of prognostic biomarkers in the urinary peptidome of the small renal mass. Am J Pathol 189(12):2366–2376. https://doi.org/10.1016/j.ajpath.2019.08.015
Lim W, Kim H-S (2019) Exosomes as therapeutic vehicles for cancer. Tissue Eng Regen Med. https://doi.org/10.1007/s13770-019-00190-2
Kurahashi R, Kadomatsu T, Baba M, Hara C, Itoh H, Miyata K, Endo M, Morinaga J, Terada K, Araki K (2019) MicroRNA-204-5p: a novel candidate urinary biomarker of Xp11. 2 translocation renal cell carcinoma. Cancer Sci 110(6):197
Huang T, Song C, Zheng L, Xia L, Li Y, Zhou Y (2019) The roles of extracellular vesicles in gastric cancer development, microenvironment, anti-cancer drug resistance, and therapy. Mol Cancer 18(1):62
Fredsøe J, Rasmussen AK, Mouritzen P, Borre M, Ørntoft T, Sørensen KD (2019) A five-microRNA model (pCaP) for predicting prostate cancer aggressiveness using cell-free urine. Int J Cancer 145(9):2558–2567
Scott E, Munkley J (2019) Glycans as biomarkers in prostate cancer. Int J Mol Sci 20(6):1389
Munkley J, Mills IG, Elliott DJ (2016) The role of glycans in the development and progression of prostate cancer. Nat Rev Urol 13(6):324
Tkac J, Bertok T, Hires M, Jane E, Lorencova L, Kasak P (2019) Glycomics of prostate cancer: Updates. Expert Rev Proteomics 16(1):65–76
Güllü Amuran G, Tinay I, Filinte D, Ilgin C, Peker Eyüboğlu I, Akkiprik M (2020) Urinary micro-RNA expressions and protein concentrations may differentiate bladder cancer patients from healthy controls. Int Urol Nephrol 52(3):461–468. https://doi.org/10.1007/s11255-019-02328-6
Matsuda A, Kuno A, Yoshida M, Wagatsuma T, Sato T, Miyagishi M, Zhao J, Suematsu M, Kabe Y, Narimatsu H (2020) Comparative glycomic analysis of exosome subpopulations derived from pancreatic cancer cell lines. J Proteome Res 19(6):2516–2524
Royo F, Cossio U, Llop J, Falcón-Pérez JM (2018) Modifications of the glycome of extracellular vesicles affect their biodistribution in mice. J Extracell Vesicles 7:216–217
Song W, Zhou X, Benktander JD, Gaunitz S, Zou G, Wang Z, Novotny MV, Jacobson SC (2019) In-depth compositional and structural characterization of N-Glycans derived from human urinary exosomes. Anal Chem 91(21):13528–13537
D’Agati VD, Kaskel FJ, Falk RJ (2011) Focal segmental glomerulosclerosis. N Engl J Med 365(25):2398–2411. https://doi.org/10.1056/NEJMra1106556
Gebeshuber CA, Kornauth C, Dong L, Sierig R, Seibler J, Reiss M, Tauber S, Bilban M, Wang S, Kain R, Bohmig GA, Moeller MJ, Grone HJ, Englert C, Martinez J, Kerjaschki D (2013) Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1. Nat Med 19(4):481–487. https://doi.org/10.1038/nm.3142
Huang Z, Zhang Y, Zhou J, Zhang Y (2017) Urinary exosomal miR-193a can be a potential biomarker for the diagnosis of primary focal segmental glomerulosclerosis in children. BioMed Res Int 2017:6. https://doi.org/10.1155/2017/7298160
Delić D, Eisele C, Schmid R, Baum P, Wiech F, Gerl M, Zimdahl H, Pullen SS, Urquhart R (2016) Urinary exosomal miRNA signature in type II diabetic nephropathy patients. PLoS ONE. https://doi.org/10.1371/journal.pone.0150154
Gudehithlu KP, Hart P, Joshi A, Garcia-Gomez I, Cimbaluk DJ, Dunea G, Arruda JA, Singh AK (2019) Urine exosomal ceruloplasmin: a potential early biomarker of underlying kidney disease. Clin Exp Nephrol 23(8):1013–1021
Solé-Marcé C, Cortés-Hernández J, Vidal M, Felip ML, Ordi-Ros J (2015) THU0377 MIR-29C in urinary exosomes as predictor of early renal fibrosis in lupus nephritis. Ann Rheum Dis 74(Suppl 2):332–333. https://doi.org/10.1136/annrheumdis-2015-eular.4578
Baglio S, Masoumi N, Tsang-a-Sjoe M, Mv Eijndhoven, Heutinck K, Jordanova E, ten Berge R, Grundberg K, Schiffelers R, van den Wetering J, de Wildt K, Verkuijlen S, Roelofs J, Bultink I, Middeldorp J, Voskuyl A, Pegtel D (2018) S2D:5 Exosomes target renal tubular epithelial cells transferring inflammatory epstein–barr virus-encoded small rna (eber1) in lupus nephritis patients. Lupus Sci Med 5(Suppl 1):A8–A9. https://doi.org/10.1136/lupus-2018-abstract.10
Solé-Marcé C, Garcia-Vives E, Agraz I, Ordi-Ros J, Cortés-Hernández J (2019) THU0236 urinary exosomal MIR-31, MIR-107 AND MIR-135B-5P from tubular renal cells as responder biomarker in lupus nephritis. Ann Rheum Dis 78(Suppl 2):395–396. https://doi.org/10.1136/annrheumdis-2019-eular.5346
Garcia-Vives E, Solé C, Moliné T, Vidal M, Agraz I, Ordi-Ros J, Cortés-Hernández J (2020) The urinary exosomal miRNA expression profile is predictive of clinical response in lupus nephritis. Int J Mol Sci 21(4):1372
Chen CC, Liu L, Ma F, Wong CW, Guo XE, Chacko JV, Farhoodi HP, Zhang SX, Zimak J, Segaliny A, Riazifar M, Pham V, Digman MA, Pone EJ, Zhao W (2016) Elucidation of exosome migration across the blood-brain barrier model in vitro. Cell Mol Bioeng 9(4):509–529. https://doi.org/10.1007/s12195-016-0458-3
Iliescu FS, Vrtačnik D, Neuzil P, Iliescu C (2019) Microfluidic technology for clinical applications of exosomes. Micromachines 10(6):392
Contreras-Naranjo JC, Wu H-J, Ugaz VM (2017) Microfluidics for exosome isolation and analysis: enabling liquid biopsy for personalized medicine. Lab Chip 17(21):3558–3577
Ashcroft BA, de Sonneville J, Yuana Y, Osanto S, Bertina R, Kuil ME, Oosterkamp TH (2012) Determination of the size distribution of blood microparticles directly in plasma using atomic force microscopy and microfluidics. Biomed Microdevices 14(4):641–649. https://doi.org/10.1007/s10544-012-9642-y
Kanwar SS, Dunlay CJ, Simeone DM, Nagrath S (2014) Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes. Lab Chip 14(11):1891–1900
Zhang P, He M, Zeng Y (2016) Ultrasensitive microfluidic analysis of circulating exosomes using a nanostructured graphene oxide/polydopamine coating. Lab Chip 16(16):3033–3042
Vaidyanathan R, Naghibosadat M, Rauf S, Korbie D, Carrascosa LG, Shiddiky MJ, Trau M (2014) Detecting exosomes specifically: a multiplexed device based on alternating current electrohydrodynamic induced nanoshearing. Anal Chem 86(22):11125–11132
Yang X-X, Sun C, Wang L, Guo X-L (2019) New insight into isolation, identification techniques and medical applications of exosomes. J Controlled Release 308:119–129
Awdishu L, Tsunoda S (2019) Identification of maltase glucoamylase as a biomarker of acute kidney injury in patients with cirrhosis. Crit Care Res Pract 2019:5912804. https://doi.org/10.1155/2019/5912804
Sonoda H, Lee BR, Park KH, Nihalani D, Yoon JH, Ikeda M, Kwon SH (2019) miRNA profiling of urinary exosomes to assess the progression of acute kidney injury. Sci Rep 9(1):4692. https://doi.org/10.1038/s41598-019-40747-8
Barros ER, Carvajal CA (2017) Urinary exosomes and their cargo: potential biomarkers for mineralocorticoid arterial hypertension? Front Endocrinol. https://doi.org/10.3389/fendo.2017.00230
Khurana R, Ranches G, Schafferer S, Lukasser M, Rudnicki M (2017) Identification of urinary exosomal noncoding RNAs as novel biomarkers in chronic kidney disease. RNA 23(2):142–152. https://doi.org/10.1261/rna.058834.116
Zang J, Maxwell AP, Simpson DA (2019) Differential expression of urinary exosomal microRNAs miR-21-5p and miR-30b-5p in individuals with diabetic kidney disease. Sci Rep 9(1):10900. https://doi.org/10.1038/s41598-019-47504-x
Doi T (2019) Involvement of Elf3 on Smad3 activation-dependent injuries in podocytes and excretion of urinary exosome in diabetic nephropathy. PLoS ONE. https://doi.org/10.1371/journal.pone.0216788
Acknowledgements
The authors thank the Portuguese Foundation for Science and Technology (FCT), European Union, QREN, FEDER and COMPETE for funding UnIC—Unidade de Investigação Cardiovascular (UIDB/00051/2020 and UIDP/00051/2020), iBiMED (UID/04501/2020, POCI-01-0145-FEDER-007628) and FCT QOPNA ((FCT UID/QUI/00062/2019) and LAQV/REQUIMTE (UIDB/50006/2020) research units. RV is supported by IF/00286/2015 grants. VT is supported by Mahidol University research grant and the Thailand Research Fund (IRN60W0004).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Vitorino, R., Ferreira, R., Guedes, S. et al. What can urinary exosomes tell us?. Cell. Mol. Life Sci. 78, 3265–3283 (2021). https://doi.org/10.1007/s00018-020-03739-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-020-03739-w